Published in Neuroimage on November 01, 2004
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
Impulsivity, attention, memory, and decision-making among adolescent marijuana users. Psychopharmacology (Berl) (2012) 2.36
Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc (2007) 2.05
Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology (2009) 1.82
Adolescent brain development and the risk for alcohol and other drug problems. Neuropsychol Rev (2010) 1.71
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One (2013) 1.59
Altered white matter microstructure in adolescent substance users. Psychiatry Res (2009) 1.58
The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend (2007) 1.54
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav (2010) 1.51
Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res (2008) 1.50
Sleep disturbance in heavy marijuana users. Sleep (2008) 1.49
Age of onset of marijuana use and executive function. Psychol Addict Behav (2011) 1.46
Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry (2005) 1.43
Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend (2009) 1.40
Acute effects of cocaine on the neurobiology of cognitive control. Philos Trans R Soc Lond B Biol Sci (2008) 1.38
Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 1.37
Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res Rev (2010) 1.34
Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend (2009) 1.32
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin Chem (2013) 1.29
Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol (2009) 1.29
Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol (2011) 1.23
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) (2010) 1.22
Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature. Clin Psychol Rev (2006) 1.20
Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology (Berl) (2006) 1.19
Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res (2011) 1.18
Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci (2007) 1.18
Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res (2010) 1.18
Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res (2011) 1.17
A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction (2015) 1.16
Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J Clin Exp Neuropsychol (2012) 1.15
Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc (2011) 1.15
Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol (2006) 1.10
Neurocognitive correlates of white matter quality in adolescent substance users. Brain Cogn (2009) 1.10
Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology (2009) 1.09
Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J Subst Abuse Treat (2008) 1.07
Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology (Berl) (2010) 1.05
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology (2012) 1.03
Age of onset of marijuana use impacts inhibitory processing. Neurosci Lett (2012) 1.02
Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology (2006) 1.02
Who are those "risk-taking adolescents"? Individual differences in developmental neuroimaging research. Dev Cogn Neurosci (2014) 0.96
Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction. Cereb Cortex (2012) 0.95
Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. Psychopharmacology (Berl) (2012) 0.93
Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. Eur Neuropsychopharmacol (2008) 0.93
Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des (2014) 0.92
Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage (2011) 0.92
Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology (Berl) (2012) 0.91
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study. Psychopharmacology (Berl) (2012) 0.91
Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol (2010) 0.90
Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology (2014) 0.85
Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology (Berl) (2010) 0.83
The effect of cannabis use on memory function: an update. Subst Abuse Rehabil (2013) 0.83
Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans. Psychopharmacology (Berl) (2011) 0.82
Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder. Drug Alcohol Depend (2013) 0.81
Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits. Psychopharmacology (Berl) (2009) 0.81
Cortico-cerebellar abnormalities in adolescents with heavy marijuana use. Psychiatry Res (2012) 0.81
Preliminary functional MRI results from a combined stop-signal alcohol-cue task. J Stud Alcohol Drugs (2014) 0.81
Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances. Neurobehav HIV Med (2012) 0.80
Functional imaging of implicit marijuana associations during performance on an Implicit Association Test (IAT). Behav Brain Res (2013) 0.80
Prefrontal hypoactivity associated with impaired inhibition in stimulant-dependent individuals but evidence for hyperactivation in their unaffected siblings. Neuropsychopharmacology (2013) 0.80
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory. Psychopharmacology (Berl) (2011) 0.80
Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review. J Addict Dis (2009) 0.80
Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend (2007) 0.79
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans. PLoS One (2013) 0.78
Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats. Psychopharmacology (Berl) (2015) 0.78
Neural correlates of performance monitoring in chronic cannabis users and cannabis-naive controls. J Psychopharmacol (2013) 0.77
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. J Anal Toxicol (2015) 0.76
Assessing topographical orientation skills in cannabis users. ScientificWorldJournal (2012) 0.76
Specificity of Executive Functioning and Processing Speed Problems in Common Psychopathology. Neuropsychology (2017) 0.75
Mismatch Negativity and P50 Sensory Gating in Abstinent Former Cannabis Users. Neural Plast (2016) 0.75
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition. Curr Addict Rep (2017) 0.75
The effects of cannabis use on salience attribution: a systematic review. Acta Neuropsychiatr (2016) 0.75
The effects of synthetic cannabinoids on executive function. Psychopharmacology (Berl) (2017) 0.75
Self-reported Cognitive Scales in a U.S. National Survey: Reliability, Validity, and Preliminary Evidence for Associations with Alcohol and Drug Use. Addiction (2017) 0.75
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry (2004) 3.02
Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage (2005) 2.15
Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology (2002) 2.07
Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci (2008) 1.96
A population-average MRI-based atlas collection of the rhesus macaque. Neuroimage (2008) 1.94
Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage (2003) 1.87
Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiatry (2008) 1.81
Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study. Environ Health Perspect (2004) 1.77
Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend (2005) 1.71
Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology (2005) 1.70
The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend (2007) 1.54
Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry (2007) 1.52
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. J Nucl Med (2008) 1.51
Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatry (2011) 1.50
Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am J Psychiatry (2003) 1.36
2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J (2003) 1.26
Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers. Brain Res Cogn Brain Res (2005) 1.23
Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc (2005) 1.21
Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction (2009) 1.21
Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans. Drug Alcohol Depend (2005) 1.20
Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure. Neuroimage (2007) 1.12
Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset. Br J Psychiatry (2013) 1.10
Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend (2007) 1.08
Cumulative lead dose and cognitive function in older adults. Epidemiology (2009) 1.07
Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380. Neuroimage (2007) 1.04
The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility. Addict Behav (2010) 1.02
Role of dietary iron restriction in a mouse model of Parkinson's disease. Exp Neurol (2004) 0.97
Stress hormone responses to corticotropin-releasing hormone in substance abusers without severe comorbid psychiatric disease. Biol Psychiatry (2003) 0.96
Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration. Eur J Pharmacol (2002) 0.96
Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology (Berl) (2009) 0.91
Protein kinase C activity and the relations between blood lead and neurobehavioral function in lead workers. Environ Health Perspect (2002) 0.86
Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death. Brain Res Mol Brain Res (2005) 0.86
Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroin. Neuropsychopharmacology (2002) 0.83
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse (2003) 0.82
Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension. PLoS One (2011) 0.82
EEG deficits in chronic marijuana abusers during monitored abstinence: preliminary findings. Ann N Y Acad Sci (2003) 0.81
Methamphetamine causes alterations in the MAP kinase-related pathways in the brains of mice that display increased aggressiveness. Neuropsychopharmacology (2006) 0.80
EEG of chronic marijuana users during abstinence: relationship to years of marijuana use, cerebral blood flow and thyroid function. Clin Neurophysiol (2007) 0.79
Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol (2008) 0.79
Neuropsychiatric alterations in MDMA users: preliminary findings. Ann N Y Acad Sci (2005) 0.79
Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores. J Occup Environ Med (2006) 0.79
Education-associated cortical glucose metabolism during sustained attention. Neuroreport (2005) 0.79
Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend (2007) 0.79
Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users. J Clin Exp Neuropsychol (2011) 0.78
Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression. Ann N Y Acad Sci (2004) 0.76
Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys. Neuropsychopharmacology (2007) 0.76
Cognitive performance profiles by latent classes of drug use. Am J Addict (2014) 0.75